Rheumatology NewsMeta-analysis: Bisphosphonates mitigate glucocorticoid-induced bone lossJuly 5, 2017Rheumatoid ArthritisOsteoporosis
Rheumatology NewsIn Sweden, very few osteoporotic fractures prompt treatment within 12 monthsJune 21, 2017Osteoporosis
Rheumatology NewsRomosozumab cuts new vertebral fracture risk by 73%, but safety data are concerningJune 15, 2017Osteoporosis
Rheumatology NewsFor vertebral osteomyelitis, early switch to oral antibiotics is feasibleMay 11, 2017OsteoporosisOrthopedics
Rheumatology NewsAntacid use in infants linked to increased fracture riskMay 9, 2017PediatricsOsteoporosis
Rheumatology NewsUpdated osteoporosis guideline advocates bisphosphonates, nixes estrogensMay 8, 2017Osteoporosis
Rheumatology NewsIn sickle cell disease, osteomyelitis is a tough callMay 3, 2017PediatricsOsteoporosis
Rheumatology NewsStudy shows no adverse events with long-term denosumab in postmenopausal womenApril 14, 2017Osteoporosis
Rheumatology NewsNew guidance: Bone health is front and center in functional hypothalamic amenorrhea careMarch 25, 2017Osteoporosis
Rheumatology NewsLarge, intermittent vitamin D doses may increase fracture, fall risk in elderlyMarch 3, 2017Osteoporosis
Rheumatology NewsTargeting Paget’s bone symptoms supported in long-term trialFebruary 8, 2017Osteoporosis
